Invention Grant
US09227938B2 Pharmaceutical composition containing crystalline sorafenib tosylate
有权
含有结晶索拉非尼甲苯磺酸盐的药物组合物
- Patent Title: Pharmaceutical composition containing crystalline sorafenib tosylate
- Patent Title (中): 含有结晶索拉非尼甲苯磺酸盐的药物组合物
-
Application No.: US14371034Application Date: 2013-01-23
-
Publication No.: US09227938B2Publication Date: 2016-01-05
- Inventor: Stefan Scheler , Heiko Degendorfer , Johannes Raneburger , Franz Schwarz
- Applicant: Stefan Scheler , Heiko Degendorfer , Johannes Raneburger , Franz Schwarz
- Applicant Address: CH Basel
- Assignee: SANDOZ AG
- Current Assignee: SANDOZ AG
- Current Assignee Address: CH Basel
- Agency: Manelli Selter PLLC
- Agent Jeffrey S. Melcher
- Priority: EP12152165 20120123
- International Application: PCT/EP2013/051219 WO 20130123
- International Announcement: WO2013/110644 WO 20130801
- Main IPC: A61K31/4412
- IPC: A61K31/4412 ; C07D213/81 ; A61K9/20 ; A61K9/00 ; A61K47/20
Abstract:
The present invention relates to an oral solid dosage form, in particular a tablet, comprising sorafenib tosylate polymorphic form III.
Public/Granted literature
- US20150080435A1 PHARMACEUTICAL COMPOSITION CONTAINING CRYSTALLINE SORAFENIB TOSYLATE Public/Granted day:2015-03-19
Information query
IPC分类:
